More than two in three Americans approve of President Biden’s signature legislation, the Inflation Reduction Act. The law is growing our economy, bolstering domestic manufacturing, and spurring ...

The Inflation Reduction Act (IRA) of 2022 empowered Medicare to negotiate prices for certain prescription drugs with high levels of Medicare spending. However, prices for new drugs cannot be ...

Biologics are diverse, organic-based treatments like vaccines and gene therapy, requiring specific conditions for effectiveness. Unlike small molecules, biologics show batch variability and involve ...

Biologics, with their precision targeting, expand treatment options for a multitude of diseases - from cancer to autoimmune disorders. In 2023 alone, 10 antibody therapeutics received their first ...

The Inflation Reduction Act of 2022, which includes provisions requiring Medicare to negotiate lower drug prices for some of the United States’ most costly drugs, marks the first time in decades that ...

(MENAFN- GlobeNewsWire - Nasdaq) The aseptic fill finish manufacturing market is witnessing growth opportunities driven by the rising demand for biologics, vaccines, and sterile injectables.

- This best-of-breed partnership will expedite sterile injectables to patients through the optimized transfer of bulk drug substance to finished drug product. OKLAHOMA CITY & WILMINGTON, ...

Sex differences in the prevalence, severity, and disability associated with pain are well documented in both clinical and preclinical research. Despite ...

Dublin, March 11, 2026 (GLOBE NEWSWIRE)-- The "Aseptic Fill Finish Manufacturing Market (2nd Edition) by Type of Molecule, Type of Biologic Manufactured, Type of Packaging Container, Scale of ...